Fulvestrant Injection
Product Images NDC 0781-3532

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Fulvestrant (NDC 0781-3532). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Fulvestrant Sdz Room 01)

FDA Label Image

Figure-2 (Fulvestrant Sdz Room 02)

FDA Label Image

Figure 3.jpg (Fulvestrant Sdz Room 03)

FDA Label Image

Figure 4.jpg (Fulvestrant Sdz Room 04)

FDA Label Image

Figure 5.jpg (Fulvestrant Sdz Room 05)

FDA Label Image

Structural Formula (Fulvestrant Sdz Room 06)

FDA Label Image

Figure 6.jpg (Fulvestrant Sdz Room 07)

The text provided seems to be a table displaying the proportion of patients who are progression-free over time for two different doses of a medication called Fulvestrant (250 mg and 500 mg). It also lists the number of patients at risk for each dose at different time intervals. The specific values for each dose and time interval are not clearly readable due to errors.*

FDA Label Image

Figure 7.jpg (Fulvestrant Sdz Room 08)

FDA Label Image

Figure 8.jpg (Fulvestrant Sdz Room 09)

FDA Label Image

Figure-9 (Fulvestrant Sdz Room 10)

FDA Label Image

Figure-10 (Fulvestrant Sdz Room 11)

FDA Label Image

Figure 11.jpg (Fulvestrant Sdz Room 12)

FDA Label Image

Figure 12.jpg (Fulvestrant Sdz Room 13)

FDA Label Image

Fig_13.jpg (Fulvestrant Sdz Room 14)

FDA Label Image

Fig_14.jpg (Fulvestrant Sdz Room 15)

FDA Label Image

Carton (Image 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.